Top 5 Risers
|
| Stock |
Rating |
Analysis |
| CLMT |
STRONGBUY |
The projected value for Calumet is still rising quickly even though past earnings have already improved significantly. |
| CF |
STRONGBUY |
The long term projected growth rate for CF is rising, and this is happenening at a time when historical earnings have already increased significantly. |
| PIR |
BUY |
Pier 1 is one of the top candidates projected to achieve both higher than previously projected earnings in the short run and a higher earnings growth rate in the long run. |
| SPPI |
BUY |
Spectrum Pharmaceuticals has shown a remarkable increase in projected value recently, with the majority of analysts expecting higher than previously expected earnings. |
| BAC |
STRONGBUY |
The recent earnings history for Bank Of America shows significant improvement while projected valuation continues to rise. |